Company News

Should you buy shares in Saga?

Here are some quick comments on the Saga IPO from skimming the prospectus before all the media do their in-depth analysis of what will no doubt be examined as a possible punt by both the millions of Saga customers and stock market speculators. Saga customers are favoured slightly in that they get one free share for every 20 purchased if they hold them for a year - hardly enough I suggest to sway my decision being one of their customers. But ...

Thoughts on AstraZeneca

Shareholders in AstraZeneca are no doubt pleasantly surprised by the uplift in the share price following the offers from Pfizer. The share price has doubled in the last year on improving prospects with an even sharper increase in the last few weeks as soon as a bid was rumoured. That puts the company on a historic p/e of about 20 at the time of writing. AstraZeneca has of course been a dog for some years with falling revenue and earnings, a poor ...

Barclays wins vote on pay

Barclays Bank Annual General Meeting yesterday showed how difficult it is to get excessive pay awards voted down. Despite strong opposition from PIRC, F&C and Standard Life (the latter actually spoke at the meeting which is unusual for institutions), only 24% of votes were cast against the Remuneration Report with an even lower number against the Remuneration Policy. There were a number of shareholders who abstained so the media commonly reported 34% of shareholders  as failing to support the board, but ...

Quindell – and how to avoid the shorters

Quindell, a company operating in the insurance sector, came under attack yesterday by Gotham City Research LLC, an investment analysis firm. Quindell's shares ended down on the day by 39% and were down more than 50% at one point. Gotham City make numerous allegations in a 74-page document which is available from their web site. Without a lot more knowledge of this company and a detailed study of these allegations, it is impossible to comment on the substance of them, but some ...

Directors’ Share Purchases at Chrysalis VCT

Would you be happy if you saw that the directors of a listed company had apparently purchased shares at an advantageous price? In other words had purchased shares in the market  at a price that was not available to anyone else? On Thursday the 17th April, I chose to purchase 3,000 shares in Chrysalis VCT. This followed an announcement by the company on the 14th April that the company had achieved two successful exits from portfolio companies which had increased the company's ...

Remuneration at Barclays and Persimmon

Barclays Bank Annual General Meeting is due next week on the 24th April. Pay of bankers is always controversial and Barclays is no exception. Pay has been going up but performance has gone down, and a rights issue is required to strengthen the company's balance sheet. The CEO, Antony Jenkins, has waived his bonus for last year, but that has not placated investors. The bonus pool has been increased and "Role Based Pay" introduced to avoid restrictions imposed by the new ...

Oxford Technology VCTs and Baronsmead VCT 3

ShareSoc has organised a meeting for those investors in the two Oxford Technology VCTs who are affected by the withdrawal of VCT status. It is scheduled for the 20th May in the City of London. Although the companies have submitted an appeal letter to HMRC, there is some doubt as to whether the appeal will be successful. See this web page for more details of the issues, and how to register for the meeting if you wish to attend:  www.sharesoc.org/campaigns/oxford-technology-vcts/. The ...

BP Annual General Meeting Report

With the AGM season now in full swing, it's worth pointing out that ShareSoc makes available many useful reports on such meetings. These are available to all ShareSoc subscribing members in an archive here. Below is an abbreviated sample of one by ShareSoc Chairman Stan Grierson on last weeks meeting of BP. THE BP AGM 2014 As always BP’s AGM is both the first and one of the biggest of the season, and took place at the ExCel Centre on Thursday 10th April. ...

Impressions of a self-publicist, and Blinkx

ShareSoc has covered the case of Blinkx in previous reports. Yesterday Prof. Edelman spoke at the UK Investor Show. He was given a 45 minute session, but spent a lot of it establishing his credentials by going over some of the common past abuses in internet advertising. For example he asked "why is the internet a wild west?" and answered it by saying "because nobody is paying attention", although he later talked about FTC (Federal Trade Commission) action in that area. ...

Insurance companies and Kentz

With the attack by the Government on annuities in the budget and the revelation that the FCA is to look into the treatment of some policyholders such as those in "closed" funds, both investors in these companies and their directors must be somewhat incensed. Indeed the Financial Times reported this morning that half a dozen of the City's top institutional investors have consulted a leading law firm over alleged "market abuse" in the way the latter review was disclosed. It seems ...